Login to Your Account



Pharma: Other News To Note


Tuesday, August 7, 2012
• Curemark LLC, of Rye, N.Y., received FDA clearance for enrollment of children ages 9-12 into its open-label extension study of CM-AT for children with autism.

To continue reading subscribe now to BioWorld Today

Learn More about BioWorld Today

Already a subscriber? Sign In or Buy now to activate your subscription